Zai Lab Limited
Zai Lab Limited (ZLAB) Financial Performance & Income Statement Overview
Review Zai Lab Limited (ZLAB) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Zai Lab Limited (ZLAB) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Zai Lab Limited ZLAB financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $106.49M | $109.07M | $102.27M | $100.50M |
| Cost of Revenue | $38.65M | $42.09M | $36.92M | $35.23M |
| Gross Profit | $67.84M | $66.98M | $65.35M | $65.27M |
| Gross Profit Ratio | $0.64 | $0.61 | $0.64 | $0.65 |
| R&D Expenses | $60.73M | $52.25M | $65.98M | $61.63M |
| SG&A Expenses | $63.42M | $82.62M | $67.22M | $79.71M |
| Operating Expenses | $124.15M | $134.87M | $133.20M | $141.34M |
| Total Costs & Expenses | $162.80M | $176.96M | $170.12M | $176.57M |
| Interest Income | $8.61M | $9.09M | $9.03M | $9.33M |
| Interest Expense | $1.19M | $904000.00 | $745000.00 | $492000.00 |
| Depreciation & Amortization | $3.46M | $3.03M | $2.87M | $2.94M |
| EBITDA | -$43.79M | -$77.75M | -$38.05M | -$76.84M |
| EBITDA Ratio | -$0.41 | -$0.71 | -$0.37 | -$0.76 |
| Operating Income | -$56.31M | -$67.89M | -$67.85M | -$76.06M |
| Operating Income Ratio | -$0.53 | -$0.62 | -$0.66 | -$0.76 |
| Other Income/Expenses (Net) | $7.87M | -$13.79M | $26.18M | -$4.21M |
| Income Before Tax | -$48.44M | -$81.68M | -$41.67M | -$80.28M |
| Income Before Tax Ratio | -$0.45 | -$0.75 | -$0.41 | -$0.80 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$48.44M | -$81.68M | -$41.67M | -$80.28M |
| Net Income Ratio | -$0.45 | -$0.75 | -$0.41 | -$0.80 |
| EPS | -$0.04 | -$0.08 | -$0.43 | -$0.82 |
| Diluted EPS | -$0.04 | -$0.08 | -$0.43 | -$0.82 |
| Weighted Avg Shares Outstanding | $1.08B | $1.03B | $97.59M | $97.59M |
| Weighted Avg Shares Outstanding (Diluted) | $1.08B | $1.03B | $97.59M | $97.59M |
The company's financials show resilient growth, with revenue advancing from $100.50M in Q2 2024 to $106.49M in Q1 2025. Gross profit remained healthy with margins at 64% in Q1 2025 compared to 65% in Q2 2024. Operating income hit -$56.31M last quarter, sustaining a consistent -53% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$43.79M. Net income rose to -$48.44M, while earnings per share reached -$0.04. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan